CliniSys has acquired laboratory information management systems provider, ApolloLIMS.

ApolloLIMS  specialises in clinical, public health, toxicology and molecular diagnostics and its team will join CliniSys as part of the acquisition.

The acquisition confirms a significant step toward fulfilling CliniSys’ vision to enable a new wave of digital diagnostics and community laboratories, spanning environmental, water quality, public health, toxicology and agriculture laboratory testing markets.

Michael Simpson, CEO at CliniSys, said: “ApolloLIMS and its team bring tremendous expertise to CliniSys. Not only will they help expand our knowledge of diagnostics within and beyond the clinical laboratory, but they share our deep belief that the future of digital diagnostics lies in the cloud.

“With the addition of ApolloLIMS, we are now poised to seize new opportunities to quickly expand our offerings in community and public health diagnostics, and to help better track and prevent disease.”

All current ApolloLIMS customers will continue to be supported as normal, and over time the company’s solution will be integrated into the CliniSys product family as the business accelerates the roadmap for its next-generation SaaS product strategy.

Eric Dingfelder, SVP and general manager at HORIZON and ApolloLIMS, said: “ApolloLIMS’ diverse expertise helps us push the boundaries of the diagnostics market and enable organisations and governments to better fight the spread of disease.

“Modern laboratories need the very best technology platforms to streamline their workflows and improve disease monitoring. Joining CliniSys ensures ApolloLIMS’ customers of that future.”

CliniSys’ acquisition of ApolloLIMS comes after they acquired Horizons Lab Systems earlier in the year, a laboratory information management company. This, along with the addition of ApolloLIMS, is all part of CliniSys’ ultimate goal to include a new wave of digital diagnostics and laboratories across the care and community sector.